These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 8988841

  • 1. Liposomal delivery of the herpes simplex virus thymidine kinase gene in glioma: improvement of cell sensitization to ganciclovir.
    Zerrouqi A, Rixe O, Ghoumari AM, Yarovoi SV, Mouawad R, Khayat D, Soubrane C.
    Cancer Gene Ther; 1996; 3(6):385-92. PubMed ID: 8988841
    [Abstract] [Full Text] [Related]

  • 2. Gene transfer in hepatocarcinoma cell lines: in vitro optimization of a virus-free system.
    Ghoumari AM, Rixe O, Yarovoi SV, Zerrouqi A, Mouawad R, Poynard T, Opolon P, Khayat D, Soubrane C.
    Gene Ther; 1996 Jun; 3(6):483-90. PubMed ID: 8789797
    [Abstract] [Full Text] [Related]

  • 3. Actions of HSVtk and connexin43 gene delivery on gap junctional communication and drug sensitization in hepatocellular carcinoma.
    Ghoumari AM, Mouawad R, Zerrouqi A, Nizard C, Provost N, Khayat D, Naus CC, Soubrane C.
    Gene Ther; 1998 Aug; 5(8):1114-21. PubMed ID: 10326035
    [Abstract] [Full Text] [Related]

  • 4. Delivery of herpes simplex thymidine kinase bystander effect by engineered human mesothelial cells for the treatment of ovarian cancer.
    Rancourt C, Bergeron C, Lane D, Garon G, Piché A.
    Cytotherapy; 2003 Aug; 5(6):509-22. PubMed ID: 14660047
    [Abstract] [Full Text] [Related]

  • 5. In vitro sensitization of the B16 murine melanoma cells to ganciclovir by different RNA and plasmid DNA constructions encoding HSVtk.
    Yarovoi SV, Mouawad R, Colbère-Garapin F, Soubrane C, Khayat D, Rixe O.
    Gene Ther; 1996 Oct; 3(10):913-8. PubMed ID: 8908505
    [Abstract] [Full Text] [Related]

  • 6. Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir.
    Namba H, Tagawa M, Miyagawa T, Iwadate Y, Sakiyama S.
    Cancer Gene Ther; 2000 Jun; 7(6):947-53. PubMed ID: 10880027
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Herpes simplex virus thymidine kinase/ganciclovir system in multicellular tumor spheroids.
    Finocchiaro LM, Bumaschny VF, Karara AL, Fiszman GL, Casais CC, Glikin GC.
    Cancer Gene Ther; 2004 May; 11(5):333-45. PubMed ID: 15107812
    [Abstract] [Full Text] [Related]

  • 10. In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats.
    Ram Z, Culver KW, Walbridge S, Blaese RM, Oldfield EH.
    Cancer Res; 1993 Jan 01; 53(1):83-8. PubMed ID: 8380127
    [Abstract] [Full Text] [Related]

  • 11. Gene therapy for alpha-fetoprotein-producing human hepatoma cells by adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene.
    Kanai F, Shiratori Y, Yoshida Y, Wakimoto H, Hamada H, Kanegae Y, Saito I, Nakabayashi H, Tamaoki T, Tanaka T, Lan KH, Kato N, Shiina S, Omata M.
    Hepatology; 1996 Jun 01; 23(6):1359-68. PubMed ID: 8675152
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene.
    Kim YG, Bi W, Feliciano ES, Drake RR, Stambrook PJ.
    Cancer Gene Ther; 2000 Feb 01; 7(2):240-6. PubMed ID: 10770632
    [Abstract] [Full Text] [Related]

  • 14. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
    Tang XJ, Wang YP, Zhou QH, Che GW, Chen XH, Zhu DX.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr 01; 24(2):148-52. PubMed ID: 17407070
    [Abstract] [Full Text] [Related]

  • 15. Preclinical and therapeutic utility of HVJ liposomes as a gene transfer vector for hepatocellular carcinoma using herpes simplex virus thymidine kinase.
    Hasegawa H, Shimada M, Yonemitsu Y, Utsunomiya T, Gion T, Kaneda Y, Sugimachi K.
    Cancer Gene Ther; 2001 Apr 01; 8(4):252-8. PubMed ID: 11393277
    [Abstract] [Full Text] [Related]

  • 16. Gene therapy of experimental malignant mesothelioma using adenovirus vectors encoding the HSVtk gene.
    Esandi MC, van Someren GD, Vincent AJ, van Bekkum DW, Valerio D, Bout A, Noteboom JL.
    Gene Ther; 1997 Apr 01; 4(4):280-7. PubMed ID: 9176512
    [Abstract] [Full Text] [Related]

  • 17. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation].
    Xing Y, Lu G, Xiao Y, Zeng F, Zhang Q, Xiong P, Feng W.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 10; 82(21):1484-7. PubMed ID: 12509912
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Targeted gene therapy of ovarian cancer using an ovarian-specific promoter.
    Bao R, Selvakumaran M, Hamilton TC.
    Gynecol Oncol; 2002 Feb 10; 84(2):228-34. PubMed ID: 11812079
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.